Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
microMend’s gentle application has a distinct advantage in closing wounds in the fragile skin of elderly and chronically ill patients where sutures cannot be used because they often rip right through their skin. In addition, these patients often experience minor injuries that tear their skin. These skin tears cannot be closed with any of the current wound closure products due to the fragility of these wounds. microMend has been documented to have the unique ability to effectively treat these tears.![]()
We have conducted studies that demonstrate the proficiency of our product with regard to the cosmetic outcomes and confirm that wounds can be closed seven times faster with microMend compared to sutures
Share this Article:
Tweet
|
Company
KitoTech Medical
Headquarters
Seattle, WA
Management
Paul Leung, PE, VP of Operations and Ronald Berenson, MD, President and CEO
Description
Nestled in the heart of Seattle, the team at KitoTech is equipping doctors with microMend® – an innovative next-generation wound closure product. It is designed like a butterfly bandage, but incorporates two arrays of miniature staples that the company calls Microstaples. In contrast to sutures and staples, microMend is straightforward to use and thus achieves consistent results that are independent of surgical skills. The ease of use and rapid application are microMend’s strongest suits. In a clinical study directly comparing microMend to sutures in surgery, 85 percent of doctors and nurses rated microMend superior, while 90 percent of patients rated cosmetic results better with microMend
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info